Amniocentesis is a process in which amniotic fluid is sampled using a hollow needle inserted into the uterus, to screen for abnormalities in the developing fetus. Amniocentesis tests can also be used for paternity tests. The collected sample from the uterus contains genetic material of the fetus, which can be used to screen the DNA of fetus and provide paternity test results. Ultrasound does not give precise information about the fetus, therefore doctors suggests an amniocentesis test to mother, if the family of the child has some history of genetic disorders. Increasing population of mothers aged over 35 to 45 years having child are always suggested to take amniocentesis test as the risks of baby having genetic disorders, fetal infections increases with age of mother.

Market Dynamics

Increasing prevalence of middle aged motherhood rates are highly contributing to the global amniocentesis needles market growth. According to the data from the Centre for Disease Control and Prevention (CDC) of 2016, birth rates among women aged 30 to 35 years surpassed those among women aged 25 to 30 years in the U.S. With the increasing age of mother,  prevalence of the child acquiring a genetic disease  also increases. According to a study published in  Evidence Based Birth in March 2016, the rates of having a baby with Down syndrome is 1 in 1,340 at age 25 years, 1 in 939 at age 30 years, 1 in 353 at age 35 years, 1 in 85 at age 40 years, and 1 in 35 at age 45 years.

However, amniocentesis is a safe procedure, with very low percentage of complications. The observed complications associated with the amniocentesis tests include vaginal bleeding or loss of amniotic fluid through the vagina, severe uterine cramping, high fever, redness, inflammation or infection at the site of puncture by needle, and unusual fetal activity or a lack of fetal movement. According to the American Pregnancy Association (APA) data of 2016, in U.S., the risk of miscarriage ranges from 1 in 400 to 1 in 200. In facilities where amniocentesis is performed regularly, the rates are closer to 1 in 400. Miscarriages can occur due to infection in the uterus, water breaking, or labor being induced prematurely.

Key features of the study

• This report provides in-depth analysis of the global amniocentesis needles market, market size (USD Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: (2026 – 2033), considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global amniocentesis needles market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Becton, Dickinson and Company, Biopsybell, Cook Medical, CooperSurgical, Integra Lifesciences, Laboratoire CCD, Medline, Medtronic, RI.Mos. , Rocket Medical, Smiths Medical, and Tsunami Medical
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global amniocentesis needles market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for amniocentesis needles market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

• By Product Type
  • 100mm to 150mm
  • Smaller Than 100 mm
  • Larger Than 150 mm
• By Application
  • Amniocentesis
  • Amnioreduction
  • Fetal Blood Transfusion
  • Amnioinfusion
  • Cordocentesis
• By End User
  • Hospitals
  • Diagnostic Centers
  • Clinics
• By Regional Insights
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Becton
  • Dickinson and Company
  • Biopsybell S.R.L.
  • Cook Medical Inc
  • CooperSurgical Inc.
  • Integra Lifesciences
  • Laboratoire CCD
  • Medline Industries Inc.
  • Medtronic Plc
  • MOS. S.R.L.
  • Rocket Medical Plc.
  • Smiths Medical Inc.
  • Tsunami Medical S.R.L.